The company stands out for its wide range of activities and the robustness of its assets, making it a highly attractive acquisition. With complete control over the production chain, the company operates in the following areas: industry, commerce, importation, exportation, storage, distribution, repair services, courses, and training.
The brand is registered in Brazil, and over 20 products are registered with ANVISA.
Equipped with a quality system compliant with ISO 13485, the company is prepared for CE and FDA certification implementation.
It has a solid network of more than 60 distributors in Brazil, ensuring extensive market coverage. Additionally, it has its own ERP (Enterprise Resource Planning) system, ensuring efficient and well-controlled operations.
The company also develops its own projects, standing out for its capacity for innovation and adaptation to market needs.
The unit in Portugal, located at the Novotecna Technology Complex in Coimbra, is strategically positioned to facilitate expansion in Europe.
This is an unmissable opportunity for investors looking for a well-structured business with a proven track record of success and significant growth potential.
Reason for Sale: The partners, without liabilities and without heirs, are planning their retirement and are available to ensure the continuity of work until the complete transfer of know-how.
If you are looking for a solid and promising opportunity in the healthcare sector, contact us now!
pt 
